CANF · Can-Fite Biopharma Ltd American Depositary Shares each representing two (2) Ordinary Shares
View on chartInsiders & Stakes
No transactions found.
Transaction History
No transactions found.
No transactions found.
No transactions found.
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
CANF files prospectus for ~6.6M share offering
Can-Fite Biopharma has filed a prospectus for an offering of approximately 6.6 million ordinary shares on behalf of existing shareholders. The filing signals a planned secondary sale that may increase the number of shares available in the market. Shares are currently near the lower end of recent price action, with an RSI around 30, indicating limited upside pressure from the news.
CANF files prospectus for ~6.6M share offering. Can-Fite Biopharma has filed a prospectus for an offering of approximately 6.6 million ordinary shares on behalf of existing shareholders. The filing signals a planned secondary sale that may increase the number of shares available in the market. Shares are currently near the lower end of recent price action, with an RSI around 30, indicating limited upside pressure from the news.